🏥NIH Notice of Closed Meetings on Grant Evaluations
The Department of Health and Human Services announces closed meetings of the National Institutes of Health to review grant applications in various scientific fields. These discussions aim to evaluate proposals that may include confidential information, impacting funding opportunities within the health research sector.
Learn More🏥Change in Meeting Format for Diabetes and Kidney Disease Advisory Council
The National Institute of Diabetes and Digestive and Kidney Diseases has issued a notice of a change in meeting format and time for the Advisory Council. The meeting will now be virtual and partially closed to the public, with new timings set from 10
Learn More❌Withdrawal of Direct Final Rule on Child Support Services
ACF published in the Federal Register on December 31, 2024, a direct final rule making technical updates throughout Title 45 Code of Federal Regulations (CFR) Chapter III. On February 27, 2025, ACF re- opened the comment period and delayed the effective date until April 28, 2025. The comment period closed March 31, 2025. ACF is withdrawing the direct final rule because the Agency received significant adverse comment.
Learn More💊NIH Notice of Closed Meeting for Drug Product Development Proposals
The Department of Health and Human Services announces a closed meeting of the National Center for Advancing Translational Sciences Special Emphasis Panel to review contract proposals related to chemistry, manufacturing, and controls for drug product development. The meeting will take place via video format and is not open to the public.
Learn More💊FDA Approves AMVUTTRA Under Priority Review Voucher
The Food and Drug Administration (FDA) is announcing the issuance of approval of a product redeeming a priority review voucher. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the issuance of priority review vouchers as well as the approval of products redeeming a priority review voucher. FDA has determined that the supplemental application (Supplement-06) for AMVUTTRA (vutrisiran), approved March 20, 2025, meets the criteria for redeeming a priority review voucher.
Learn More📅Notice of Change in NIH Panel Meeting Schedule
The Department of Health and Human Services announces an amendment to the meeting of the Center for Scientific Review Special Emphasis Panel, changing it from a two-day to a one-day event scheduled for May 2025. This closed meeting pertains to international and cooperative project discussions for an award, indicating operational adjustments within NIH processes.
Learn More💰NIH Announces Closed Grant Review Meetings for Businesses
The Department of Health and Human Services provides notice of upcoming closed meetings related to the review of grant applications at the National Institutes of Health. These meetings are designated for the evaluation of various health and scientific topics, and specific committees are tasked with assessing applications relevant to small business activities and scientific advancements.
Learn More🏥Notice of Closed Meetings by National Heart, Lung, and Blood Institute
The Department of Health and Human Services announces closed meetings for the National Heart, Lung, and Blood Institute. These meetings will evaluate contract proposals and grant applications, with specific agendas and details about the virtual format and relevant contact individuals provided.
Learn More🏥Amended Notice of Meeting
The Department of Health and Human Services announces an amended notice for the National Advisory Council on Aging meeting, which has been changed to a virtual format with adjusted timings. The meeting will be partially closed to the public.
Learn More❌NIH Cancels National Gene Vector Biorepository Meeting
The Department of Health and Human Services announces the cancellation of the National Gene Vector Biorepository contract review meeting. This decision follows the lack of funding for the solicitation, which was previously scheduled for April 23, 2025. The notice highlights the importance of funding in the continuation of related projects and the implications of unmet financial commitments.
Learn More